Belinostat (PXD101) is a potent pan-HDAC inhibitor. It affects apoptotic and cell cycle signaling by inducing the accumulation of acetylated histones and altering gene transcription, effectively promoting apoptosis and inhibiting tumor cell proliferation.
Belinostat (PXD101) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Belinostat (PXD101) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Belinostat (PXD101) Mechanism of Action: HDAC Inhibition in T-Cell Lymphocyte Research
- Belinostat (PXD101) Clinical Trials
- Belinostat (PXD101) Working Concentration | Cell Culture | Treatment
- Belinostat (PXD101) Solubility in DMSO
- Belinostat (PXD101) Stock Solution
- Belinostat (PXD101) Storage
- Belinostat (PXD101) Stability
- Belinostat (PXD101) Combination Database
- Belinostat (PXD101) Molecular Weight
- Belinostat (PXD101) SMILES
- Belinostat (PXD101) CAS Number
- Belinostat (PXD101) Chemical Structure (2D and 3D)
- Belinostat (PXD101) Sigma (SML3010)? Try a better option.
- Belinostat (PXD101) MedChemExpress (HY-10225)? Try a better option.
- Belinostat (PXD101) APExBIO (A4612)? Try a better option.
- Belinostat (PXD101) Cayman (34084)? Try a better option.
- Belinostat (PXD101) SDS｜MSDS